Form D · Other
NuGen Medical Devices Inc.
Toronto, A6 · CIK 0001941497
Offering snapshot reported Apr 27, 2023 · SEC filing
- Reported sold
- $19.8K Offering amount: $46.2K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2023 | Initial | $19,821 | No comparison | 1 | SEC filing |
| Sep 13, 2022 | Initial | $29,410 | No comparison | 3 | SEC filing |
| Aug 5, 2022 | Initial | $38,830 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-480217
"Total Remaining to be Sold" is the aggregate purchase price of shares underlying warrants sold in this offering. U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7341 reported on April 25, 2023
Each Unit consists of 1 cm sh & 1 cm sh purchase wrt. Each wrt entitles the holder to purchase 1 cm sh at a price of CDN$0.24 for a period of 2 years following the closing date.
Source: Form D, filed Apr 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Buzbuzian | Director, Executive |
| Nicky Canton | Executive |
| William Cleman | Director |
| Philip Cortese | Director |
| Tony Di Benedetto | Director, Executive |
| Karen Dunlap | Director |
| Veronique Laberge | Executive |
| John Leombruno | Director |
| Dr. John Leombruno | Director |
| Derek Lindsay | Director |
| Michael Wright | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
18 King Street East, Suite 1400
Toronto, A6, M5C 1C4
Toronto, A6, M5C 1C4